H2AK119ub1的调节,功能和治疗策略
Yu Zhang1, Kaiwen Xu1, Keyi Zhang1
1School of Pharmacy and Science, Institute of Clinical Pharmacology, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei 230032, China.
基因组H2AK119ub1是一个关键的表观遗传标记,调节基因表达. 它的失调与疾病有关,使其调节轴成为干预的有希望的治疗目标.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 基因规则 基因规则
背景情况:
- 在氨酸119 (H2AK119ub1) 的基因组H2A单双化是一个关键的表观遗传标记.
- 它在转录控制,染色体重塑和细胞系承诺中发挥着中心作用.
- H2AK119ub1的稳态是由多镇压复合物1和二维基基因酶维持的.
研究的目的:
- 综合审查H2AK119ub1.1.的分子机制.
- 分析其在疾病进展中的作用.
- 讨论针对H2AK119ub1.1的当前和未来治疗策略.
主要方法:
- 关于分子机制的文献综述.
- 分析H2AK119ub1在各种病理中的作用.
- 对药理干预措施的检查.
主要成果:
- H2AK119ub1的沉积和提取受到严格监管.
- H2AK119ub1的失调与人类疾病有机学的联系.
- H2AK119ub1调节轴是一个可行的治疗目标.
结论:
- 了解H2AK119ub1的动态对于表观遗传调节至关重要.
- 准H2AK119ub1为疾病提供了新的治疗途径.
- 这一审查为制定有针对性的干预措施提供了一个框架.
更多相关视频
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
相关概念视频
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Spreading of Chromatin Modifications
Writers
The writer...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
